臨牀消化器内科 Vol.16 No.12(2-1)


特集名 早期消化管癌に対するEMR -- 適応拡大をめぐる問題
題名 早期胃癌に対するEMR (1) 早期胃癌に対するEMRの適応拡大をめぐる問題点
発刊年月 2001年 11月
著者 武本 憲重 癌研究会附属病院内科
著者 小泉 浩一 癌研究会附属病院内科
著者 武藤 徹一郎 癌研究会附属病院外科
著者 柳澤 昭夫 癌研究会研究所病理
著者 加藤 洋 癌研究会研究所病理
著者 丸山 雅一 早期胃癌検診協会
【 要旨 】 早期胃癌の内視鏡的粘膜切除(EMR)の適応拡大と拡大に伴う問題点について検討した.現在の早期胃癌の絶対的な適応は,リンパ節転移のない深達度mの分化型癌で大きさは20mm以下の隆起型,または10mm以下の潰瘍合併のない陥凹型となっている.しかし,最近,手術症例を詳細に分析することにより,手術標本より分化型癌・未分化型癌ともにm癌とsm癌の一部に対しては,適応の拡大が可能であることが明らかになった.
しかし,適応の拡大にあたっては,(1)分化型癌では潰瘍合併の有無とsm浸潤の程度,(2)未分化型癌では粘膜内のIIb様拡がり,潰瘍合併の有無およびsm浸潤の程度について癌組織型別に検討し決定する必要がある.病変を一括切除する工夫により,適応基準を満たしたすべての病変はEMRの適応になると考えられた.
Theme Expansion of Indications for Endoscopic Mucosal Resection of Early Gastrointinal Cancer
Title Some Problems with Expansion of Indications for Endoscopic Mucosal Resection of Early Gastric Carcinomas
Author Norishige Takemoto Division of Internal Medicine, Cancer Institute Hospital, Japanese Foundation for Cancer
Author Kouichi Koizumi Division of Internal Medicine, Cancer Institute Hospital, Japanese Foundation for Cancer
Author Tetsuichiro Muto Division of Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer
Author Akio Yanagisawa Department of Pathology, Cancer Institute, Japanese Foundation for Cancer
Author Yoh Kato Department of Pathology, Cancer Institute, Japanese Foundation for Cancer
Author Masakazu Maruyama Foundation for Detection of Gastric Early Carcinoma
[ Summary ] Some problems related to the expansion of the indications for endoscopic mucosal resection (EMR) were reconsidered, based on 934 early gastric cancer lesions, which bad been operated on between 1989 and 1998 at the Cancer Institute Hospital. At the present time, EMR is absolutely indicated for a lesion which satisfy the following conditions: in differentiated carcinoma a polypoid and elevated lesion measuring 20mm or less, without associated ulceration, and depressed lesions, measuring 10mm or less without associated ulceration. Recently, however, it has been proven that EMR can be carried out on some mucosal and submucosal carcinomial lesions which does not satisfy the current conditions for EMR indications. In our study, a new direction on the expansion of the indications for EMR was revealed. In cases of mucosa carcinoma, not associated with ulceration, all differentiated lesions and undifferentiated lesions measuring 20mm or less were indicated for EMR. In cases of mucosal carcinoma, which is associated with ulceration, undifferentiated lesions measuring 30mm or less and undifferentiated lesions measuring 5mm or less were indicated for EMR. In cases of submucosal carcinoma, which were not accompanied with ulceration or vessel permeation, differentiated lesions with the size of 30mm and the depth of submucosal invasion of 600 micron meter or less, and undifferentiated lesions under 10mm, and the depth of 600 micron meter and less were indicated for EMR.
戻る